List of companies in Boxer Capital's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Cabaletta Bio is a biotechnology company developing cellular therapies for autoimmune disease. | ||||||
Codiak Biosciences is a biotechnology company developing exosome therapeutics. | ||||||
Avidity Biosciences is a biotechnology company developing RNA-based therapeutics that is headquartered in San Diego, California. | ||||||
Atreca is a biotechnology company founded in 2011 by Jonathan Woo, Guy Cavet, Tito A Serafini, Daniel Emerling, Paulette Dillon, Wayne Volkmuth and Yann Chong Tan. | ||||||
Small Molecules | ||||||
Solid Biosciences is a Cambridge, Massachusetts-based biotechnology company focused on solving Duchenne muscular dystrophy. | ||||||
IDEAYA Biosciences is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality | ||||||
Akero Therapeutics is a Cambridge, Massachusetts-based biotechnology company focused on reversing the NASH epidemic by restoring the body's metabolism to a balanced state. | ||||||
Encoded Therapeutics is a developer of genomics-driven precision medicine targeting and treating genetic diseases and disorders. | ||||||
Achilles Therapeutics is a personalized Cancer T cell Therapies targeting neoantigens founded in 2016. | ||||||
Boundless Bio is a pioneer in understanding and treating the most intractable cancers. They have charted a new spatial map of the cancer genome within cancer cells and are harnessing their scientific founders' discoveries about "extrachromosomal DNA," or ecDNA, to drive a revolution in cancer therapeutics. | ||||||
Prevail Therapeutics is a New York City-based biotechnology company and a wholly owned subsidiary of Eli Lilly and Company. | ||||||
Silverback Therapeutics is a Seattle-based biopharmaceutical company developing ImmunoTAC therapies targeting previously inaccessible disease pathways. | ||||||
A pharmaceutical company that develops therapies targeting solid and hematological cancer tumors | ||||||
A biotechnology company offering precision immunotherapy cancer treatments. | ||||||
Milestone Pharmaceuticals is a small Molecules founded in 2007. | ||||||
REVOLUTION Medicines is a small Molecules founded in 2014. | ||||||
Rain Therapeutics is a small Molecules founded in 2017 by Avanish Vellanki. | ||||||
Elevation Oncology is an oncology Company founded by Shawn M. Leland. | ||||||
Black Diamond Therapeutics is a Biotechnology company. | ||||||
Day One Biopharmaceuticals is a cancer Treatments founded in 2018. | ||||||
Ceptur Therapeutics is Revolutionizing RNA Therapeutics with U1 Adaptor Technology to Develop Medicines for Unaddressed Diseases | ||||||
Tango Therapeutics is a cancer Therapeutics, Immuno-Oncology. | ||||||
Cedilla Therapeutics is a company founded in 2018. | ||||||
Halda is inventing novel precision medicines for oncology. Specifically, we are developing RIPTAC™ therapeutics, a new drug modality for the treatment of cancer. Founded by world renowned Yale scientist, Professor Craig Crews, Halda invented RIPTAC therapeutics as an innovative cancer treatment approach that does not rely on traditional oncogenic |
